Literature DB >> 30126575

Creative Collaborations in Antimicrobial Stewardship: Using the Centers for Disease Control and Prevention's Core Elements as Your Guide.

Priya Nori1, Yi Guo2, Belinda Ostrowsky3.   

Abstract

Antimicrobial stewardship program (ASP) success and growth rely on recurring collaborations with partners within the health care system, such as administration, clinical services, infection prevention, pharmacy, the medical school, and microbiology. These collaborations present valuable opportunities for development of hospital policies, institutional guidelines, and educational curriculum. External opportunities for collaboration may be less frequent but equally valuable. These collaborations are facilitated by health system partnerships with national quality organizations, neighboring ASPs, and the Department of Health. All collaborations present novel opportunities for policy development, research initiatives, and expanding the regional ASP footprint.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial stewardship programs; Core elements of stewardship; Multidisciplinary; Quality collaboratives

Mesh:

Substances:

Year:  2018        PMID: 30126575     DOI: 10.1016/j.mcna.2018.05.001

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  2 in total

Review 1.  Diagnostic Bacteriology in District Hospitals in Sub-Saharan Africa: At the Forefront of the Containment of Antimicrobial Resistance.

Authors:  Jan Jacobs; Liselotte Hardy; Makeda Semret; Octavie Lunguya; Thong Phe; Dissou Affolabi; Cedric Yansouni; Olivier Vandenberg
Journal:  Front Med (Lausanne)       Date:  2019-09-23

2.  Perspective of Pakistani Physicians towards Hospital Antimicrobial Stewardship Programs: A Multisite Exploratory Qualitative Study.

Authors:  Khezar Hayat; Meagen Rosenthal; Ali Hassan Gillani; Panpan Zhai; Muhammad Majid Aziz; Wenjing Ji; Jie Chang; Hao Hu; Yu Fang
Journal:  Int J Environ Res Public Health       Date:  2019-05-05       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.